GR3031051T3 - Derivatives of indole, indazole and benzisoxazole for the treatment of schizophrenia - Google Patents

Derivatives of indole, indazole and benzisoxazole for the treatment of schizophrenia

Info

Publication number
GR3031051T3
GR3031051T3 GR990402129T GR990402129T GR3031051T3 GR 3031051 T3 GR3031051 T3 GR 3031051T3 GR 990402129 T GR990402129 T GR 990402129T GR 990402129 T GR990402129 T GR 990402129T GR 3031051 T3 GR3031051 T3 GR 3031051T3
Authority
GR
Greece
Prior art keywords
benzisoxazole
pyrrolidin
indazole
indole
ylü
Prior art date
Application number
GR990402129T
Other languages
English (en)
Inventor
Gilbert Lavielle
Olivier Muller
Mark Millan
Valerie Audinot
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of GR3031051T3 publication Critical patent/GR3031051T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
GR990402129T 1995-06-07 1999-08-20 Derivatives of indole, indazole and benzisoxazole for the treatment of schizophrenia GR3031051T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9506663A FR2735129B1 (fr) 1995-06-07 1995-06-07 Nouveaux derives de l'indole, de l'indazole et du benzisoxazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
GR3031051T3 true GR3031051T3 (en) 1999-12-31

Family

ID=9479672

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402129T GR3031051T3 (en) 1995-06-07 1999-08-20 Derivatives of indole, indazole and benzisoxazole for the treatment of schizophrenia

Country Status (15)

Country Link
US (1) US5703070A (el)
EP (1) EP0747379B1 (el)
JP (1) JPH08333362A (el)
CN (1) CN1060772C (el)
AT (1) ATE183183T1 (el)
AU (1) AU702285B2 (el)
CA (1) CA2178302C (el)
DE (1) DE69603667T2 (el)
DK (1) DK0747379T3 (el)
ES (1) ES2137638T3 (el)
FR (1) FR2735129B1 (el)
GR (1) GR3031051T3 (el)
NO (1) NO309090B1 (el)
NZ (1) NZ286756A (el)
ZA (1) ZA964842B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
GB9718712D0 (en) * 1997-09-03 1997-11-12 Merck Sharp & Dohme Theraputic Agents
GB9718833D0 (en) * 1997-09-04 1997-11-12 Merck Sharp & Dohme Therapeutic agents
GB9805716D0 (en) * 1998-03-17 1998-05-13 Merck Sharp & Dohme Therapeutic agents
GB9815317D0 (en) * 1998-07-15 1998-09-16 Merck Sharp & Dohme Therapeutic agents
GB9816263D0 (en) 1998-07-24 1998-09-23 Merck Sharp & Dohme Therapeutic agents
US6627645B2 (en) * 2000-04-28 2003-09-30 Acadia Pharmaceuticals, Inc. Muscarinic agonists
AU2003248091A1 (en) * 2002-07-19 2004-02-09 Meiji Dairies Corporation Indole derivatives and drugs containing the same
WO2009076404A1 (en) * 2007-12-10 2009-06-18 Epix Delaware, Inc. Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
US8569282B2 (en) 2007-12-11 2013-10-29 Cytopathfinder, Inc. Carboxamide compounds and their use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2708913A1 (de) * 1976-03-04 1977-09-08 Hoechst Ag Benzoylpiperidyalkyl-indole und verwandte verbindungen
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
US5030639A (en) * 1987-07-13 1991-07-09 Hoechst-Roussel Pharmaceuticals Inc. N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents
US4980365A (en) * 1987-07-13 1990-12-25 Hoechst-Roussel Pharmaceuticals Inc. N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents
FR2644786B1 (fr) * 1989-03-21 1993-12-31 Adir Cie Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2654104B1 (fr) * 1989-11-07 1992-01-03 Adir Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2716680B1 (fr) * 1994-02-25 1996-04-05 Adir Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
FR2735129A1 (fr) 1996-12-13
CN1143642A (zh) 1997-02-26
CA2178302C (fr) 2002-02-26
AU5473596A (en) 1996-12-19
EP0747379B1 (fr) 1999-08-11
DK0747379T3 (da) 2000-01-31
ATE183183T1 (de) 1999-08-15
DE69603667T2 (de) 2000-03-09
CA2178302A1 (fr) 1996-12-08
NO962360L (no) 1996-12-09
NO962360D0 (no) 1996-06-06
EP0747379A1 (fr) 1996-12-11
ZA964842B (en) 1997-01-07
US5703070A (en) 1997-12-30
NZ286756A (en) 1997-08-22
CN1060772C (zh) 2001-01-17
AU702285B2 (en) 1999-02-18
FR2735129B1 (fr) 1997-07-11
JPH08333362A (ja) 1996-12-17
NO309090B1 (no) 2000-12-11
ES2137638T3 (es) 1999-12-16
DE69603667D1 (de) 1999-09-16

Similar Documents

Publication Publication Date Title
ES2116801T3 (es) Empleo de derivados de adamantano para el tratamiento de tinnitus.
PT91417A (pt) Processo para a preparacao de derivados indolicos
PT88255A (pt) Processo para a preparacao de derivados do indole
NO941884D0 (no) 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler
GR3031051T3 (en) Derivatives of indole, indazole and benzisoxazole for the treatment of schizophrenia
PT655243E (pt) Derivados da melatonina para utilizacao no tratamento de disturbios do sono
FI921308A (fi) Foerfarande foer framstaellning av derivat av substituerad imidazol-2-on
NZ329853A (en) 4-piperidinyl substituted 2-amino indane derivatives and medicaments
ATE229513T1 (de) Disubstituierte trans-3,4,4a,5,6,10b-hexahydro-2h-napht(1,2-b)- ,4-oxazine, verfahren zu deren herstellung und diese enthaltende pharmazeutigsche zusammensetzungen
NO913543L (no) Fremgangsmaate for fremstilling av 3-(1h-indazol-3-yl)-4-pyridinaminer og mellomprodukter, og anvendelse som medikamenter.
ES2181387T3 (es) Derivados de azetidinocarboxamida para el tratamiento de trastornos del sistema nervioso central.
AU1621392A (en) New 1-amidooctahydropyrido(2,1-c)(1,4)oxazine compounds, processes for preparing these and pharmaceutical compositions containing them